心肌损伤标志物的应用及临床意义

陈冀莹

心肌损伤标志物的应用及临床意义

陈冀莹

文章导航 > 国际放射医学核医学杂志 > 2004, 28 > 5: (216-219)

引用本文:

Citation:

心肌损伤标志物的应用及临床意义

陈冀莹

300192 天津, 中国医学科学院中国协和医科大学放射医学研究所
中图分类号: R446.1

The application and clinical value of markers of myocardial damage

CHEN Ji-ying

Institute of Radiation Medicine, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin 300192, China
CLC number: R446.1

摘要: 心肌损伤标志物在心肌损伤和急性心肌梗死的诊断方面起到重要作用。寻找和筛选灵敏、特异、早期的心肌损伤标志物和简便、快捷、灵敏的检测分析方法,一直是该领域的重要研究内容。目前,快速检测心肌标志物的床旁检测方法有很多,这些方法在心肌损伤的诊断及治疗中起着枢纽作用。
- 心肌损伤标志物 /
- 肌钙蛋白 /
- 心肌损伤
Abstract: Cardiac markers are presently a hot topic of studying. They now have a major role for diagnosis myocardial damage and acute myocardial infarction. It is important to search and screen a sensitive, specific and early markers of myocardial damage. The quick, accurate and sensitive assay methodology is still an important research in this field. Therefore rapid muli-analyte point-of-care tests have facilitated the use of cardiac markers for clinical management and guidance of therapy.
- cardiac markers /
- troponin /
- myocardial damage
本作品遵循Signature-Non-Commercial Use 4.0 International (CC BY-NC 4.0)协议

[1]	Azzazy HME,Christenson RH.Cardiac markers of acute coronary syndromes:is there a case for point-of-care testing)[J].Clin Biochem,2002,35(1):13-27.
[2]	Alpert JS,Thygesen K,Antman E,et al.Myocardial infarction rede-fineda consensus document of The Joint European Society of Cardiology/Am College of Cardiology Committee for the redefinition of myocardial infarction[J].J Am Coll Cardiol,2000,36:959-969.
[3]	Davis GK.Role of cardiac troponin testing in percutaneous transluminal coronary angioplasty[J]. Scand J Clin Lab Invest,2003,63(3):167-174.
[4]	Nakata T,Hashimoto A,Hase M,et al.Human heart-type fatty acid-binding protein as an early diagnostic and prognostic marker in acute coronary syndrome[J].Cardiology,2003,99:96-104.
[5]	Okamoto F,Sohmiya K,Ohkaru Y,et al.Human heart-type cytoplasmic fatty acid-binding protein (H-FABP) for the diagnosis of acute myocardiac infarction.Clinical evaluation of H-FABP in comparison with myoglobin and creatine kinase isoenzyme MB[J].Clin Chem Lab Med,2000,38:231-238.
[6]	Maisel A.B-type natriuretic peptide in the diagnosis and manage-meng of congestive heart failure[J].Cardiol Clin,2001,19(4):557-571.
[7]	Dao Q,Krishnaswamy P,Kazanegra R,et al.Vtility of B type natriuretic peptide in the diagnosis of congestive heart failure in an ur-gentcare setting[J].J Am Coll Cardiol,2001,37:379-385.
[8]	James SK,Lindah B,Siegbahn A,et al.N-terminal probrain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary disease[J].Circulation,2003,108:275-281.
[9]	Venugopal J.Cardiac natriuretic peptides-hope or hype?[J]. Clin Pharm Ther,2001,26(1):15-31.
[10]	Rafav N,Ridker PM.High-sensitivity C-reative protein:a novel and promising marker of coronary heart disease[J].Clin Chem,2001,47(3):403-411.
[11]	Hainaut C,Gade W.The emerging roles of BNP and accelerated cartiac protoco in emergency laboratory medicine[J].Clin Lab Sci,2003,16(3):166-178.
[12]	Christenson RH,Duh SH,Apple FS,et al.Standardization of cardiac tropinin I assays:round robin of ten candidate reference materials[J].Clin Chem,2001,47(3):431-437.
[13]	Zaninotto M,Pagani F,Altinier S,et al.Multicenter evaluation of five assays for myoglobin determination[J]. Clin Chem,2000,46(10):1631-1637.
[14]	Collinson PO,Boa FG,Gaze DC.Measurement of cardiac tropinins[J].Ann Clin Biochem,2001,38:423-449.
[15]	Stiegler H,Fisher Y,Vazquez-Jimenez JF,et al.Lower cardiac troponin T and I results in heparin-plasma than in serum[J].Clin Chem,2000,46(9):1338-1349.
[16]	Panteghini M,Gerhardt W,Apple FS,et al.Quality specifications for cardiac troponin assays[J].Clin Chem Lab Med,2001,39(2):174-178.

[1]	李波 . 心肌肌钙蛋白T及其在某些心脏疾患中的应用. 国际放射医学核医学杂志, 2000, 24(5): 205-209.
[2]	赵保健 . 心肌肌钙蛋白Ⅰ的临床应用及检测方法进展. 国际放射医学核医学杂志, 2003, 27(5): 212-215.
[3]	赵若愚 , 鲍逸民 , 杨永青 . 血浆心肌细胞损伤标志物检测急性心肌梗死患者心肌损伤的临床研究. 国际放射医学核医学杂志, 2014, 38(4): 235-238. doi: 10.3760/cma.j.issn.1673-4114.2014.04.007
[4]	马铁军 , 王毅 , 杨莹 , 冯伟 , 李冕 . 蛋白标志物在辐射损伤中的应用. 国际放射医学核医学杂志, 2010, 34(3): 179-182. doi: 10.3760/cma.j.issn.1673-4114.2010.03.015
[5]	成明慧 , 龙伟 , 徐文清 . 辐射损伤相关生物标志物的研究进展. 国际放射医学核医学杂志, 2021, 45(2): 118-123. doi: 10.3760/cma.j.cn121381-202009038-00019
[6]	周兆明 , 马思聪 , 文磊 , 成杰 , 刘浩 , 陈龙华 , 周美娟 , 周平坤 , 蔡林波 , 周成 . 放射性肺损伤小鼠晚期转录水平特征性基因标志物的研究. 国际放射医学核医学杂志, 2019, 43(4): 340-348. doi: 10.3760/cma.j.issn.1673-4114.2019.04.008
[7]	刘怀印 , 闵长庚 . ¹¹¹In-抗肌球蛋白Fab的心肌显像对扩张期的肥厚性心肌病心肌损伤的评价. 国际放射医学核医学杂志, 1992, 16(2): 94-94.
[8]	周伶伶 , 梁瑞金 , 殷亮 . CT灌注成像联合血脑屏障损伤标志物对脓毒症相关性脑病的诊断价值. 国际放射医学核医学杂志, 2019, 43(3): 242-249. doi: 10.3760/cma.j.issn.1673-4114.2019.03.008
[9]	徐欣 , 陆毅 . 肿瘤标志物. 国际放射医学核医学杂志, 1994, 18(6): 278-281.
[10]	黄滋庠 , 赵惠杨 , 张永令 . 作为心肌梗死标志的血清肌红蛋白测定. 国际放射医学核医学杂志, 1981, 5(1): 64-65.